CURE SYNGAP1 Jun 5 2026 CURE SYNGAP1 501(c)(3) is pleased to announce a $130,000 grant to Dr. Helen Willsey and Dr. David Kastner at the University of California, San Francisco (UCSF). This funding extends Dr. Willsey's identification of SYNGAP1's role in cilia formation to investigate how its disruption impacts brain anatomy and behavior, potentially leading to more precise therapies for patients with SYNGAP1-Related Disorders (SRD). Building on previous discoveries that SYNGAP1 protein